GE vs LFCR · P/E 44, rev $13.35B vs rev $75.5M
GE Aerospace (GE) versus Lifecore Biomedical Inc. (LFCR) — a side-by-side from cached financials, not a winner call.
GE Aerospace (GE) is a aerospace & defense company listed on NYSE. It is led by Larry Culp.
Lifecore Biomedical Inc. (LFCR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported GE revenue for 2026-06-30 was $13.35B. Net income was $2.37B. Revenue was up 7.7% from 2026-03-31 to 2026-06-30. GE currently screens at market cap $373.04B and trailing P/E 44.4.
Latest reported LFCR revenue for 2025-12-31 was $75.5M. Net income was -$18.0M. Revenue was up 771.6% from 2025-06-30 to 2025-12-31. LFCR currently screens at market cap $207.1M.
GE currently screens at market cap $373.04B and trailing P/E 44.4. LFCR currently screens at market cap $207.1M.
Not investment advice. Open the GE and LFCR stock pages for the full models.
Not investment advice.